Episodic disability questionnaire (EDQ) measurement properties among adults living with HIV in Canada, Ireland, United Kingdom, and United States
-
Published:2024-01-10
Issue:1
Volume:24
Page:
-
ISSN:1471-2334
-
Container-title:BMC Infectious Diseases
-
language:en
-
Short-container-title:BMC Infect Dis
Author:
O’Brien Kelly K.ORCID, Erlandson Kristine M.ORCID, Brown Darren A.ORCID, Carusone Soo ChanORCID, Vera Jaime H.ORCID, Bergin ColmORCID, Avery LisaORCID, Bayoumi Ahmed M.ORCID, Hanna Steven E.ORCID, Harding RichardORCID, Solomon PatriciaORCID, Clair-Sullivan Natalie St.ORCID, O’Shea Noreen, Murray Carolann, Boffito MartaORCID, Da Silva George, Torres Brittany, McDuff KieraORCID, Davis Aileen M.ORCID
Abstract
Abstract
Background
The Episodic Disability Questionnaire (EDQ) is a generic 35-item patient-reported outcome measure of presence, severity and episodic nature of disability. We assessed the measurement properties of the Episodic Disability Questionnaire (EDQ) with adults living with HIV.
Methods
We conducted a measurement study with adults living with HIV in eight clinical settings in Canada, Ireland, United Kingdom, and United States. We electronically administered the EDQ followed by three reference measures (World Health Organization Disability Assessment Schedule; Patient Health Questionnaire; Social Support Scale) and a demographic questionnaire. We administered the EDQ only 1 week later. We assessed the internal consistency reliability (Cronbach’s alpha; > 0.7 acceptable), and test–retest reliability (Intra Class Correlation Coefficient; > 0.7 acceptable). We estimated required change in EDQ domain scores to be 95% certain that a change was not due to measurement error (Minimum Detectable Change (MDC95%)). We evaluated construct validity by assessing 36 primary hypotheses of relationships between EDQ scores and scores on the reference measures (> 75% hypotheses confirmed indicated validity).
Results
Three hundred fifty nine participants completed the questionnaires at time point 1, of which 321 (89%) completed the EDQ approximately 1 week later. Cronbach’s alpha for internal consistency ranged from 0.84 (social domain) to 0.91 (day domain) for the EDQ severity scale, and 0.72 (uncertainty domain) to 0.88 (day domain) for the EDQ presence scale, and 0.87 (physical, cognitive, mental-emotional domains) to 0.89 (uncertainty domain) for the EDQ episodic scale. ICCs for test–retest reliability ranged from 0.79 (physical domain) to 0.88 (day domain) for the EDQ severity scale and from 0.71 (uncertainty domain) to 0.85 (day domain) for the EDQ presence scale. Highest precision was demonstrated in the severity scale for each domain (MDC95% range: 19–25 out of 100), followed by the presence (MDC95% range: 37–54) and episodic scales (MDC95% range:44–76). Twenty-nine of 36 (81%) construct validity hypotheses were confirmed.
Conclusions
The EDQ possesses internal consistency reliability, construct validity, and test–retest reliability, with limited precision when administered electronically with adults living with HIV across in clinical settings in four countries. Given the measurement properties, the EDQ can be used for group level comparisons for research and program evaluation in adults living with HIV.
Funder
Canada Research Chairs National Institutes of Health Fondation Alma and Baxter Ricard Chair in Inner City Health at St. Michael’s Hospital and the University of Toronto
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases
Reference53 articles.
1. Serrao R, Pinero C, Velez J, Coutinho D, Maltez F, Lino S, Sarmento ECR, Tavares AP, Pacheco P, Lopes MJ, et al. Non-AIDS-related comorbidities in people living with HIV-1 aged 50 years and older: the AGING POSITIVE study. Int J Infect Dis. 2019;79:94–100. 2. S Zicari, L Sessa, N Cotugno, A Ruggiero, E Morrocchi, C Concato, S Rocca, P Zangari, EC Manno, P Palma. Immune activation inflammation and Non-AIDS Co-Morbidities in HIV-Infected patients under long-term ART. Viruses. 2019;11:200. 3. Guaraldi G, Palella FJ Jr. Clinical implications of aging with HIV Infection: perspectives and the future medical care agenda. AIDS. 2017;31(Suppl 2):129-S135. 4. O’Brien KK, Bayoumi AM, Strike C, Young NL, Davis AM. Exploring disability from the perspective of adults living with HIV/AIDS: development of a conceptual framework. Health Qual Life Outcomes. 2008;6:76. 5. O’Brien KK, Davis AM, Strike C, Young NL, Bayoumi AM. Putting episodic disability into context: a qualitative study exploring factors that influence disability experienced by adults living with HIV/AIDS. J Int AIDS Soc. 2009;12:5.
|
|